Published February 25, 2010 | Version v1
Journal article

Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study

  • 1. Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem (Israel)
  • 2. School of Dental Medicine, Hadassah-Hebrew University, Jerusalem (Israel)
  • 3. Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa (Israel)
  • 4. Department of Maxillofacial Prosthetics, Hadassah-Hebrew University Medical Center, Jerusalem (Israel)

Description

The purpose of this pilot study was to detect a correlation between serum cytokine levels and severity of mucositis, necessitating installation of a percutaneous endoscopic gastrostomy tube (PEG) in head and neck (H&N) cancer patients receiving combined chemo-radiation therapy. Fifteen patients with H&N epithelial cancer were recruited to this study. All patients received radiotherapy to the H&N region, with doses ranging from 50-70 Gy. Chemotherapy with cisplatin, carboplatin, 5-fluorouracil and taxanes was given to high-risk patients, using standard chemotherapy protocols. Patients were evaluated for mucositis according to WHO common toxicity criteria, and blood samples were drawn for inflammatory (IL-1, IL-6, IL-8, TNF-α) and anti-inflammatory (IL-10) cytokine levels before and during treatment. A positive correlation was found between IL-6 serum levels and severity of mucositis and dysphagia; specifically, high IL-6 levels at week 2 were correlated with a need for PEG tube installation. A seemingly contradictory correlation was found between low IL-8 serum levels and a need for a PEG tube. These preliminary results, indicating a correlation between IL-6 and IL-8 serum levels and severity of mucositis and a need for a PEG tube installation, justify a large scale study

Availability note (English)

Available from http://dx.doi.org/10.1186/1748-717X-5-16; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837669

Additional details

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
5
Journal Page Range
p. 16
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47029411
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CHEMOTHERAPY; CORRELATIONS; HEAD; INSTALLATION; LYMPHOKINES; NECK; NEOPLASMS; PATIENTS; TUBES; URACILS
Descriptors DEC
AZINES; BODY; DISEASES; GROWTH FACTORS; HETEROCYCLIC COMPOUNDS; HYDROXY COMPOUNDS; MEDICINE; MITOGENS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; PROTEINS; PYRIMIDINES; THERAPY

Optional Information

Copyright
Copyright (c)2010 Meirovitz et al
Notes
PMCID: PMC2837669; PUBLISHER-ID: 1748-717X-5-16; PMID: 20184737; OAI: oai:pubmedcentral.nih.gov:2837669; licensee BioMed Central Ltd.